EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Metabolic dysfunction-associated fatty liver disease as a mediator of urolithiasis risk: evidence from cross-sectional and genetic studies

Lin-Tao Miao, Wen-Jie Wang, Jin-Zhou Xu, Ming-Liang Zhong, Yuan Gong, Cong Li, Yang Xun, Shao-Gang Wang

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.106824 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Lin-Tao Miao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Urolithiasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UrolithiasisHumansCross-Sectional StudiesMaleMiddle AgedMendelian Randomization AnalysisFemaleRisk FactorsGenome-Wide Association StudyChinaAdultAgedPrevalenceGenetic Predisposition to Disease

Stichwörter der Autor:innen

Mediation analysisMendelian randomizationcross-sectional studymetabolic dysfunction-associated fatty liver diseasenonalcoholic fatty liver diseaseurolithiasis

Autor:innen und Institutionen

  • Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Health Management Center, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.

Zitieren

APA

Miao, L. T., Wang, W. J., Xu, J. Z., Zhong, M. L., Gong, Y., Li, C., Xun, Y., & Wang, S. G. (2025). Metabolic dysfunction-associated fatty liver disease as a mediator of urolithiasis risk: evidence from cross-sectional and genetic studies. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.106824

Vancouver

Miao LT, Wang WJ, Xu JZ, Zhong ML, Gong Y, Li C, et al. Metabolic dysfunction-associated fatty liver disease as a mediator of urolithiasis risk: evidence from cross-sectional and genetic studies. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.106824

BibTeX
@article{Miao2025,
  author = {Miao, Lin-Tao and Wang, Wen-Jie and Xu, Jin-Zhou and Zhong, Ming-Liang and Gong, Yuan and Li, Cong and Xun, Yang and Wang, Shao-Gang},
  title = {Metabolic dysfunction-associated fatty liver disease as a mediator of urolithiasis risk: evidence from cross-sectional and genetic studies},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.106824}
}
Kostenlos starten →